Food4 thought
Regular
Depression has set in
Depression has set in
Cheers, apparently it's on BRN investor relation page, but I can't find it?
Valuation: $Aus1, seems fair IMO.
I think it's a paid report, if you look at the last page, it's like a Pitt Street report but still they have to be realistic, and it gives you a very good overview of the company.
Parts of page 1 below:
05 May 2025
On the edge of a breakthrough
Brainchip’s technology has the potential to be implemented in the field of
Edge AI and recent research/licensing deals they’ve secured indicate the
growing interest in the capabilities and prospects of the Akida platform.
Key Messages
Potential game-changer for Edge AI adoption: Brainchip’s neuromorphic
technology can handle complex computations and enable AI applications but at a
lower power consumption. These are essential for Edge AI, which is the next area
of growth given it could address the constraints of current AI infrastructure. Their
technology had been explored by NASA, US Air force (AFRL), Mercedes Benz and
eventually licensed by companies in semiconductor and space industries. We
believe Brainchip is set to secure more licensing deals with the recent introduction
of Akida 2.0 and TENNs architecture and eventual release of newer products.
Strong management execution and expertise: Despite challenges in
commercialization, funding, and retirement of co-founders, Brainchip furthered the
development of Akida, regained some research/licensing deals, and attracted key
personnel with extensive background in semiconductors, AI, robotics, and
experience with companies such as Qualcomm, HP, IBM, Intel, and ARM Holdings.
Investment Thesis and Valuation
Potential acquisition target: Over the years, there has been increasing investments
being made into Edge AI and neuromorphic computing. An established company
(i.e. ARM Holdings, NVIDIA, Intel etc) looking to expand into these fields may acquire
BrainChip, given the capabilities and potential of the Akida IP platform.
Valuation of $1.00: We valued Brainchip through several methodologies using
scenario analysis (+291% upside), M&A comparables (+265% upside) and real
options (+712% upside). At the current share price, BRN is trading at a 16x premium
relative to FY24 NAV and 17x relative to FY24 NTA.
Catalysts and Risks
More licensing deals amid increasing Edge AI adoption: We expect more licensing
deals to be announced in the next 12 months, amid the recent release of their new
architecture called TENNs and increasing growth of the Edge AI environment.
Risk to investment thesis: The key risks that Brainchip faces are uncertainty on
further licensing deals, realization of royalty revenues, pace of Edge AI adoption,
funding for R&D and commercialization.
NOTE: Strong management execution and expertise!
Now that should really get them going over at the HC, LOL.
Calling me blind, huh?If it doesn't getting you going, then there is clearly something seriously wrong with your thinking..
A valuation that is $0.59 lower then the last paid for valuation, and have you actually read the report and what is says about having to raise money over the next five years because licence fees can only cover a fraction of their cash expenses?
You are so blind, you can't even see what's happening right in front of your eyes.
Calling me blind, huh?
There are different scenarios Mr negative.
You go on ignore, I am not wasting anymore time on you.
Bye bye.
More than disappointing, it’s appalling, how can the company get any traction when they don’t respond to queries about the product they are trying to get out and into use.Thought I'd check what the outcome, if any, was with the above enquiry through DeGirum for access to Akida.
The requestor looked like a reasonable connection to have playing with Akida.
Appears maybe not just SH's they struggle to communicate with
Bit disappointing given this simple request started in Feb....is it BRN or is it DeGirum
View attachment 84400 View attachment 84401
I'm trying to gauge when this report was written. Little doubt it has been commissioned by BRN.Good stuff. Now go and read the whole report and tell me how that is good...
Anyone reading this report would be wondering how the hell this share price is ever going to go up..
I can't understand for the life of me why BRN would actually have published this (paid) for research.... Unbelievable...
Yeah, I didn't use the words I was thinking of to describe it.More than disappointing, it’s appalling, how can the company get any traction when they don’t respond to queries about the product they are trying to get out and into use.
I'm trying to gauge when this report was written. Little doubt it has been commissioned by BRN.
A couple of points.....
1) It states that the last call on LDA was March 2024
2) Also mentions redomicle to the US
On Feb 27 2025, BRN released both the current call on LDA and the redomicle announcements. So, did the BoD have to leak our own info via the asx platform to cover for the fact we had told Trim Capital about the redomicle and they were putting it in their report???
And why have we not informed the market that the redomicle is now dead in the water and a move is off the table???
And this bit sucks too!!!!
View attachment 84423
Did you not see the AGM.It is dated 5 May 2025... one day before the AGM.... funny how they release it today and not before the AGM...
@FJ-215 why do you think the redomicile is dead and off the table? It's mentioned and explained in this research piece, why BRN want to do the redomicile..
Yeah, I didn't use the words I was thinking of to describe it.
Especially if the guy that was enquiring was the one I think it is who co authored a paper on autonomous driving with others including one associated with VW too.
Would be good if they could get their hands on Akida to try FFS.
Did you not see the AGM.
Antonio killed it, dead, buried!
yes I did see the AGM.. but that's not my understanding.... here's what said..It's not perfect as transcribed by iphone, but you get the picture from it....Needs to be released on the ASX!!!
Hi @manny100,The Trim report may have been paid for but the Acquistion value was based on actual events so it cannot be disputed.
Paid is irrelevant for this purpose.
Interesting transcript.yes I did see the AGM.. but that's not my understanding.... here's what said..It's not perfect as transcribed by iphone, but you get the picture from it....
I personally read this, as they are continuing their investigation and shareholders will be advised of Brainchips recommendation in due course. Definitely not dead.
The research is also dated 5 May and mentions a possible Nasdaq listing (and the reasons why. That clearly came from BrainChip...
From AGM : Antonio -
You're seeing some of us make some noise in the market about possible redomicile. Our bullishness is starting to show. The company must now look forward, remain looking forward. I believe we can't and shouldn't look backwards in any form. Let's talk about read domiciling, let me stress.
No decisions of any sort have been made with respect to redomicile, our announcement, and I've got lots of questions on this. Lots of questions, lots of very good questions, by the way, on this.
No decision has been made with respect to redomicile. Our announcement was only to let the market know we're investigating the matter. In our investigation and discussions, we're talking with bankers, we're talking with advisors, we're talking with legal people, we're talking to other companies.
If something develops, if something develops, we will certainly share all options and evaluate properly what is in the best interest of the company and our shareholders. And ultimately, rest assured, the shareholders will decide. I have instructed the Board that we'll investigate it. We'll put something forward when that time comes. Maybe we won't, but if we do, the shareholders will decide.
So my first my first concern with your question is.
Who from Brainchip said were redomiciling to the US.
Yeah.
I specifically said the.
: It didn't say to the US. OK, OK.
So let me let me make the record straight. There is no position from the company in any I'm sorry.
Again as correct. I'm just I'm just clarifying the record. The question insinuated that the company has said it's moving to the US and I'm just reaffirming the position. That is not what we said. All it said is we're looking at potential redomicile. We are investigating it. That could be to Europe, that could be to Canada, that could be to the US, that could be somewhere else. We don't know. And, and, and, and hold on, I don't want to get into an.
You're out of order. You're out of order. I've made it very clear. There is no decision on redomicile. I just want to be clear. I want to answer your question, but I just want to be clear on that point, OK? The only reason we shared that information with the marketplace was because we feared a leak. As we do an investigation, it may go nowhere.
I really want to make that clear, right? So now to your point, right?
Hi JPR173yes I did see the AGM.. but that's not my understanding.... here's what said..It's not perfect as transcribed by iphone, but you get the picture from it....
I personally read this, as they are continuing their investigation and shareholders will be advised of Brainchips recommendation in due course. Definitely not dead.
The research is also dated 5 May and mentions a possible Nasdaq listing (and the reasons why. That clearly came from BrainChip...
From AGM : Antonio -
You're seeing some of us make some noise in the market about possible redomicile. Our bullishness is starting to show. The company must now look forward, remain looking forward. I believe we can't and shouldn't look backwards in any form. Let's talk about read domiciling, let me stress.
No decisions of any sort have been made with respect to redomicile, our announcement, and I've got lots of questions on this. Lots of questions, lots of very good questions, by the way, on this.
No decision has been made with respect to redomicile. Our announcement was only to let the market know we're investigating the matter. In our investigation and discussions, we're talking with bankers, we're talking with advisors, we're talking with legal people, we're talking to other companies.
If something develops, if something develops, we will certainly share all options and evaluate properly what is in the best interest of the company and our shareholders. And ultimately, rest assured, the shareholders will decide. I have instructed the Board that we'll investigate it. We'll put something forward when that time comes. Maybe we won't, but if we do, the shareholders will decide.
So my first my first concern with your question is.
Who from Brainchip said were redomiciling to the US.
Yeah.
I specifically said the.
: It didn't say to the US. OK, OK.
So let me let me make the record straight. There is no position from the company in any I'm sorry.
Again as correct. I'm just I'm just clarifying the record. The question insinuated that the company has said it's moving to the US and I'm just reaffirming the position. That is not what we said. All it said is we're looking at potential redomicile. We are investigating it. That could be to Europe, that could be to Canada, that could be to the US, that could be somewhere else. We don't know. And, and, and, and hold on, I don't want to get into an.
You're out of order. You're out of order. I've made it very clear. There is no decision on redomicile. I just want to be clear. I want to answer your question, but I just want to be clear on that point, OK? The only reason we shared that information with the marketplace was because we feared a leak. As we do an investigation, it may go nowhere.
I really want to make that clear, right? So now to your point, right?